The World Health Organization announced that clinical trials for two potential Ebola treatments will commence next week in the Democratic Republic of Congo. This decision comes as the ongoing Ebola outbreak in the DRC continues to escalate, with 1,048 confirmed cases and 277 deaths reported since May 15th. The trials aim to assess the effectiveness of these treatments in combating the virus. Health officials hope these interventions will improve survival rates and control the spread of the disease. The outbreak is concentrated within the DRC, posing a significant public health challenge for the nation and the region. Further updates on the trial progress and outcomes are expected in the coming weeks.